Artificial Intelligence
Improbable LLC Appoints Outside Managers for U.S. Defense Business
WASHINGTON, Nov. 09, 2020 (GLOBE NEWSWIRE) — Improbable LLC, a U.S. subsidiary of British technology company Improbable, today announces that it has appointed Deborah Lee James, the 23rd U.S. Secretary of the Air Force, former Under Secretary of Defense for Policy Dr. Jim Miller and former Undersecretary of Defense for Intelligence Dr. Michael Vickers to its Board of Managers.
Secretary Deborah Lee James served as the 23rd Secretary of the United States Air Force with responsibility for 660,000 military and civilian personnel and a budget of nearly $140 billion. Secretary James has deep expertise in strategic planning, risk management, public policy, cyber security, logistics and innovation. Secretary James has 15 years of executive experience in private industry. Most recently, she was the President of SAIC’s Technical and Engineering sector, a $2 billion, 8,700-person enterprise. Secretary James currently leads DLJames International LLC, a strategic advisory firm, and is a member of the Board of Directors of Textron Inc., Unisys, Systems and Technology Research, and LocatorX. She is on the Advisory Boards at Massachusetts Institute of Technology – Lincoln Laboratory and LeanIn.Org.
As Under Secretary of Defense for Policy from May 2012 to January 2014, Dr. Miller served as the principal civilian advisor to the Secretary of Defense on strategy, policy, and operations. He served as Principal Deputy Under Secretary of Defense for Policy, from April 2009 to May 2012. Dr. Miller previously served as Senior Vice President and Director of Studies at the Center for a New American Security and as Senior Vice President at Hicks and Associates, Inc. Dr. Miller is currently President of Adaptive Strategies, LLC, which provides consulting on strategy development and implementation, international engagement, and technology issues. He is a senior fellow at Johns Hopkins University’s Applied Physics Laboratory, serves on the Board of Advisors for the Center for a New American Security, and is a member of the International Institute for Strategic Studies and the Council on Foreign Relations.
Dr. Michael Vickers’ federal service has spanned nearly four decades, serving in a variety of positions as a national security decision maker and intelligence community leader. In March 2011, Dr. Vickers assumed the responsibilities as Undersecretary of Defense for Intelligence; he was the longest-serving Undersecretary of Defense for Intelligence in the department’s history. Previously, he served as the department’s first and only Assistant Secretary of Defense for Special Operations/Low-Intensity & Interdependent Capabilities from July 2007 to March 2011, and Acting Undersecretary of Defense for Intelligence from January 2011 to March 2011. Dr. Vickers serves as a board member for BAE Systems, Fed Data Holdings, Metis Solutions, and Hermetic Solutions Group. He is the Chair of the Advisory Board for SAP National Security Services and an advisory board member of General Atomics & General Atomics Aeronautical Systems, Dataminr, Orbis Operations, Beacon Global Strategies, and Predata. Dr. Vickers also serves on Government advisory boards related to national security issues.
James, Miller and Vickers join Improbable Defence Chief Executive Officer Joe Robinson, Improbable Chief Technology Officer Lincoln Wallen, and Improbable LLC President & General Manager Caitlin Dohrman to form the Improbable LLC Board of Managers.
“We are thrilled to welcome such a highly respected group of defense experts to our Board with the appointment of Secretary James, Dr. Miller and Dr. Vickers,” said Joe Robinson. “Their expertise will guide our defense operations in the U.S., and ensure we are positioned to support all requirements of the U.S. Department of Defense.”
“Improbable enables an integration of modeling, simulation, artificial intelligence/machine learning and analytics to produce the most detailed and realistic synthetic environments ever conceived,” said Dr. Miller, Chair of the Board. “I’m excited to work with my colleagues to advise Improbable on how to provide unique value to the U.S. national security community by applying the revolutionary potential of Improbable’s technology for training, planning and decision support.”
To learn more about Improbable’s work in Defense and Security, visit https://defense.improbable.io.
About Improbable LLC
Improbable LLC is a U.S. subsidiary of the London-based technology company, Improbable, and focused on serving the needs of the U.S. defense and national security community as an extension of Improbable’s global defense business. Creating combined synthetic environments for the benefit of the U.S. national security community, Improbable LLC aims to decrease the cost of preparedness while improving operational effectiveness.
About Improbable
Founded in 2012 and headquartered in London, Improbable employs more than 700 staff globally. Improbable’s games business provides better ways to make multiplayer games and helps multiplayer developers to meet any challenge. Improbable’s services include managed hosting & orchestration, networking, online services and development tools, as well as advice, support, and full co-development. Improbable also makes innovative multiplayer titles using its own technology. Improbable’s Defence business operates globally and combines its parent company’s software engineering experience with expertise in computational modelling, AI and data analytics. Its work focuses on adapting and extending Improbable’s multiplayer game technology to enable the most sophisticated military simulations and synthetic environments ever experienced. The business works across the NATO alliance and with a range of industry partners to transform planning, training and decision support in the government, defence & security community.
For media inquiries:
Daniel Griffiths
Head of Global Communications
[email protected]
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/702ba37e-f5e8-415d-bc3a-4afad0e97f46
Artificial Intelligence
Clario awarded SAS Global Service Provider Partner of the Year
This award recognizes Clario’s commitment to delivering the levels of excellence and innovation required to ensure data integrity in clinical trials.
Clario receives award for its broad endpoint technology solutions and scientific expertise, which together enhance data integrity and regulatory compliance for its customers.Clario’s services, combined with SAS® analytics solutions, set a new benchmark in data management, underscoring the value Clario brings to its customers.Coupled with Clario’s support of 62% of last year’s FDA approvals and the two recent data security certifications, these accomplishments emphasize its significant contribution to healthcare research advancements.PHILADELPHIA, April 23, 2024 /PRNewswire/ — Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced it has been awarded the 2024 SAS Global Service Provider Partner of the Year for delivering superior value to its customers. SAS, a leader in data and AI, celebrated the recipients of its annual partner awards at SAS Innovate, its flagship event for business leaders, technical users and SAS Partners. This award recognizes Clario’s commitment to excellence and innovation, which together ensure that the clinical trial data Clario delivers to its customers meets stringent data integrity standards and global regulatory compliance requirements.
Clario has consistently demonstrated its expertise in developing and integrating advanced technological solutions to meet the evolving clinical trial needs of its customers. Clario’s services, combined with SAS technology, standardize clinical data for regulatory compliance purposes. This standardization streamlines the regulatory review process, ensures data integrity, and facilitates compliance with regulatory standards set by entities such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
“We are honored to be recognized as the SAS Global Service Provider Partner of the Year. This award reaffirms our commitment to leading the way in innovative technological solutions for high-quality and more consistent clinical trials for our customers around the world,” said Jay Ferro, Chief Information, Technology and Product Officer at Clario. “Having supported 62% of the FDA approvals last year, along with our recent data security milestones ISO 27001:2022 certification and SOC2 Type II attestation, Clario is powering the advancement of healthcare research, ensuring we meet the highest standards in data management.”
Clario’s broadest endpoint technological solutions and its partnership with SAS address the challenges of data management in healthcare research. This collaboration not only ensures data integrity and streamlines regulatory processes but also underscores the value it brings to its customers.
For more information on Clario and its clinical trial data management platform, please visit Clario.com.
About Clario
Clario is a leading healthcare research and technology company that generates the highest quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence-generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints.
Clario’s science, technology, and operational experts have helped deliver over 26,000 trials and contributed to over 800 regulatory approvals in more than 100 countries. For more than 50 years, we have provided deep scientific expertise and the broadest endpoint technologies to help transform lives around the world.
Clario Media Contact:Alexis NavratilCommunications [email protected]
Logo – https://mma.prnewswire.com/media/1677749/Clario_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clario-awarded-sas-global-service-provider-partner-of-the-year-302123703.html
Artificial Intelligence
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management
LONDON, April 23, 2024 /PRNewswire/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced that it has acquired Global QMS, Inc., known as Global Q, a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. Financial terms of the transaction were not disclosed.
Global Q supports leading pharma, medtech and biotech companies by providing comprehensive access to linked and standardized workflow-ready data via its SaaS platform, Optiqs360 Digital™. The platform includes MediGPT – WorkCenter™ and MediGPT – IntelliWriter™, solutions that provide clients with interconnected data visibility and common user interfaces, across internal and external sources of record. The tools support the complex workflows and reporting needs of clinical, regulatory, product lifecycle and quality management professionals, significantly streamlining annual product reviews, medical device reports and supply chain insights.
Clarivate brings together connected data, deep expertise and intelligence solutions to empower life sciences and healthcare companies to deliver safe, effective and commercially successful treatments to patients faster. The acquisition of Global Q bolsters a robust integrated platform of life science intelligence solutions from pre-clinical and clinical offerings and further expands Clarivate capabilities in manufacturing and supply chain management to include regulatory report authoring and compliance management. The workflow and reporting capabilities of Global Q complement the Clarivate Cortellis Generics Intelligence solution for Active Pharmaceutical Ingredient (API) tracking. The addition of these cloud-based solutions will serve to embed Clarivate into critical client workflows and enable the expansion of Clarivate services into new markets.
Henry Levy, President, Life Sciences & Healthcare, Clarivate, said: “Clarivate continues to explore, develop and integrate next-generation workflow automation software that streamlines and digitizes manual workflows. The acquisition of Global Q builds on our strategy to deliver solutions that empower our clients to advance treatments that improve patient lives. The combined expertise, data and technologies of Clarivate and Global Q will help to address the client need for connected data to support complex analyses and evidence-based decisions in the life sciences.”
Mitch Hayes, Founder & Chief Executive Officer, Global QMS, Inc., said: “The acquisition of Global Q by Clarivate reinforces our joint missions to help global organizations obtain profound insights and efficiencies in bringing life-saving therapies to their patients worldwide. The combined business will further the vision of putting contextually aware intelligence directly into our customers’ workflows and facilitating their daily tasks in ways never before possible.”
Life sciences professionals responsible for new product development, manufacturing and regulatory compliance are looking to connect the dots across multiple data points to accelerate their treatment and prevention efforts and realize better patient health outcomes. Harmonized and connected data sources can address the industry need for content authoring automation spanning multiple systems and workflows. The acquisition of Global Q enables Clarivate to seamlessly tap into the digital thread market, allowing for proprietary data and insights gleaned from Clarivate solutions to frictionlessly be integrated into customer workflows.
Following the successful acquisition and integration of companies, including Decision Resources Group (DRG), Bioinfogate, Patient Connect, Dialog (part of ProQuest) and IP from MotionHall, the acquisition of Global Q further demonstrates the continuing investment by Clarivate in high-value data, analytics and innovative technology paired with deep subject matter and technical expertise within its Life Sciences and Healthcare segment.
As a trusted partner in shaping the future of healthcare, Clarivate proactively addresses industry demands through intelligence platforms that connect data and use AI and advanced analytics to revolutionize patient engagement, overcome access barriers and fulfill unmet needs. The complementary solutions of Clarivate and Global Q will better position the company in a market that favors innovative tech-enabled providers with end-to-end capabilities and unique market-leading data sets.
Forward-Looking Statements This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are difficult to predict and many of which are outside of our control. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also impair our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.
About Clarivate Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
About Global QMS, Inc.Global QMS, Inc., known as Global Q, is a provider of a cloud-based intelligent workflow platform that gives our customers an interconnected workspace that allows them to have a composite view of all their product data (“digital threads”), including internal R&D, post market, regulatory, manufacturing, and others, as well as external feeds and real-world data.
Media Contact: Catherine Daniel, Director, External Communications [email protected]
Investor Relations Contact Mark Donohue, Head of Investor Relations [email protected]
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clarivate-acquires-global-qms-inc-expanding-life-sciences–healthcare-segment-into-new-markets-302124077.html
Artificial Intelligence
9fin grows leadership team with VP Content promotion
9fin has bolstered its senior leadership team with an internal promotion for a newly created VP Content positionThe promotion demonstrates the strong bench of leadership talent at 9fin and will ensure the company’s content offering continues to be best in classThe company continues to expand with open roles in its US and UK officesNEW YORK, April 23, 2024 /PRNewswire/ — 9fin (https://9fin.com/), a news and analytics platform for debt capital markets, has announced the promotion of Will Caiger-Smith to VP Content, as the business continues to scale rapidly across Europe and the US.
Will was previously 9fin’s US Managing Editor. In his new VP Content role, he joins Jen Speirs, who was promoted to VP Operations last year, in the company’s growing leadership team.
Both VP positions have global mandates and demonstrate 9fin’s continued investment in people and its commitment to rapidly progressing talented leaders within the business.
As VP Content, Will directs all news and analytics across the editorial, credit, legal and ESG teams. The promotion comes as 9fin has expanded from its core leveraged finance coverage into private credit, distressed debt, and structured credit (CLOs) across Europe and the US. These new verticals further the company’s mission to be the #1 provider of data, news and analytics globally across debt capital markets.
Will continues to report directly to 9fin’s CEO and co-founder Steven Hunter.
Will Caiger-Smith commented:
“I joined 9fin because I believed the company and its founders had the vision and technology to build the comprehensive debt intelligence platform the market needs,” said Will. “In my two and a half years at this company, that belief has only intensified. I’m delighted to be driving forward the content side of the business.”
Steven Hunter, CEO and co-founder of 9fin, said:
“I’ve been incredibly impressed by Will’s contributions to scaling 9fin in just a couple of years. He opened and scaled our US office from scratch and has built a world-class team. I am delighted to see him promoted into a new expanded role and join Jen as part of our VP level leadership. I am excited to work with them both to take 9fin to the next level”
About 9fin
9fin is the faster, smarter way to find intelligence on leveraged credit. Our AI-powered data and analytics platform centralises everything that’s needed to analyse a credit or win a mandate in one place, helping subscribers win business, outperform their peers, and save time. 9fin is trusted by the largest asset managers in the world, leading law firms and advisers in debt capital markets, and nine of the top 10 investment banks.
Photo – https://mma.prnewswire.com/media/2394643/9fin_leadership_team_vp_content.jpg
View original content:https://www.prnewswire.co.uk/news-releases/9fin-grows-leadership-team-with-vp-content-promotion-302124480.html
-
Artificial Intelligence6 days ago
Huawei Introduces AI Technologies to Accelerate Network Transformation Towards All Intelligence in the Net5.5G Era
-
Uncategorized4 days ago
Generative AI gold rush drives IT spending — with payoff in question
-
Uncategorized4 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized4 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized4 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Uncategorized4 days ago
Can artificial intelligence reduce vehicle time to market?
-
Uncategorized4 days ago
The Ottawa Hospital doctors to try AI for patient notes
-
Artificial Intelligence7 days ago
vLex Launches Vastly Expanded Vincent Legal GenAI Toolset, and AI-Focused Co-Development Lab